Professor David Reid (University of Aberdeen) has raised concerns over the licensing of osteoporosis drugs by the National Institute for Health and Clinical Excellence (NICE). Professor Reid delivered a lecture on the treatment of osteoporosis during the British Science Festival at an event organised by the Society for Endocrinology and National Osteoporosis Society.

Full article